Kinemucil (Acetylcysteine)

Acetylcysteine breaks disulfide bonds within mucus glycoproteins, disrupting the polymer structure that makes mucus thick and sticky. This chemical action reduces viscosity, allowing cilia to move mucus more readily toward the throat for expectoration.

The appropriate dose of Kinemucil is determined by the prescribing healthcare professional based on the patient’s condition, age, and overall health. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for acetylcysteine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Kinemucil.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Kinemucil’s active ingredient, acetylcysteine, is a thiol‑containing mucolytic that directly cleaves disulfide bonds, whereas other agents like carbocisteine act by reducing mucus production. Acetylcysteine often provides faster mucus thinning, but choice of therapy depends on clinical judgment and patient tolerance.

Kinemucil should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat, and direct sunlight to maintain stability and potency.

Kinemucil is taken orally, usually as a tablet, capsule, or liquid formulation, as prescribed. The dose is swallowed with water and may be taken with or without food, depending on the prescriber’s instructions.

Serious adverse reactions, though rare, include anaphylaxis, severe bronchospasm, and potential liver enzyme elevations. Patients should seek immediate medical attention if they experience difficulty breathing, swelling of the face or throat, or signs of liver dysfunction.

Kinemucil is contraindicated in individuals with known hypersensitivity to acetylcysteine or any excipients in the formulation. Patients with a history of severe bronchospasm or those who have experienced anaphylactic reactions to mucolytics should avoid its use.